Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Mahesh R. Kudrimoti, MD

Vice-Chair of Clinical Operations
| 4.84 out of 5
55 ratings | 12 comments
Mahesh R. Kudrimoti, MD
best doctor logo
Request an Appointment Physician Referral


  • Bone Cancer Team
  • Carcinoid and Neuroendocrine Cancer Team
  • Gastrointestinal and Colorectal Cancer Team
  • Genitourinary and Prostate Cancer Team
  • Gynecologic Cancer Team
  • Head and Neck Cancer Team
  • Hematology and Blood Marrow Transplantation Team
  • Liver Cancer Team
  • Lung and Thoracic Cancer Team
  • Melanoma (Skin Cancer) Team
  • Pancreas Cancer Team
  • Hepatobiliary / Pancreatic Cancer Team
  • Radiation Oncology
  • Sarcoma Team
  • Thyroid Cancer Team
  • About

    Mahesh R. Kudrimoti, MD, is a professor of radiation oncology within the Department of Radiation Medicine of the University of Kentucky College of Medicine. He also serves as program director of UK’s Radiation Oncology Residency Program. Dr. Kudrimoti has been a part of the UK College of Medicine since 1997 when he began his residency in radiation oncology here. Prior to that, he completed his internship at Robert Packer Hospital in Sayre, PA, after earning his MD from the Post Graduate Institute of Medical Education and Research in Chandigarh, India; his MBBS from Osmania Medical College in Hyderabad, India; and his undergraduate degree from Little Flower Junior College, also in Hyderabad.

    Dr. Kudrimoti is certified by the American Board of Radiology in radiation oncology and is a member of the American Society for Radiation Oncology (ASTRO) and the American Brachytherapy Society (ABS). His research interests include head and neck cancers; mucositis; skin cancers including melanomas, sarcomas, and liver-directed therapy for primary and secondary tumors of the liver; pancreatic cancer; and biliary tumors.

    Outside of his job, Dr. Kudrimoti enjoys traveling with his wife. Together, they have travelled through 43 of the 50 states. Since moving to Kentucky from India 20 years ago, Dr. Kudrimoti has lived in several areas of the bluegrass state, including Lexington, Louisville, and Hazard.

    Personal Statement: “I’ve been here since 1997, and I’ve seen Markey grow in terms of its size and complexity. I’ve seen the technologies change, I’ve seen the evolution of our department, and I have participated in its growth. I understand where our patients come from, and I understand their limitations. I’ve learned to understand their culture, their feelings, and how they think and look at life. And we have all learned to incorporate all those things into what we do here at Markey and in our radiation oncology department.”

    Faculty Rank

    Professor of Radiation Medicine


    Osmania Medical College, Hyderabad, Andra Predesh, India


    University of Kentucky

    Robert Parker Hospital, Sayre, Pa.

    Post Graduate Institute of Medical Education and Research, Chandigarh, India

    Certifications and Special Training

    American Board of Radiology, Radiation Oncology

  • Publications


    1. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study. Mohiuddin M, Kudrimoti M, Regine W, McGrath P, Hanna N, John W. Cancer J 8(3):255-262, 2002.
    2. Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma. Spring P, Valentino J, Arnold S, Sloan D, Kenady D, Kudrimoti M, Haydon R III, Lee C, Given S, Mohiuddin M, and Regine W. Cancer 104(8):1765-1771, 2005.
    3. Randomized phase II trial of high-dose melatonin and radiation therapy for rpa class 2 patients with brain metastases (RTOG 0119). Berk L, Berkey B, Rich T, Hrushesky W, Blask D, Gallagher M, Kudrimoti M, McGarry RC, Suh J, Mehta M. Int J Radiat Oncol Biol Phys 68(3):852-7, 2007.
    4. Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma: A Randomized Controlled Trial JAMA. Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Kudrimoti MR, Fromm ML, Haddock MG, Schaefer P, Willett CG, Rich TA. 299(9):1019-1026, 2008.
    5. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Warren GW, Arnold SM, Valentino JP, Gal TJ, Hyland AJ, Singh AK, Rangnekar VM, Cummings M, Marshall JR, Kudrimoti MR. Radiother Oncol 103(1):45-8, 2012.
  • Ratings & Reviews

    | 4.84 out of 5
    55 ratings |12 comments

    The star rating is a calculation based on feedback from our patients using our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    August, 2019
    Very good, excellent, care, 100%.

    June, 2019
    good experence

    April, 2019
    I'm very satisfied with *Dr. Kudrimoti! The whole team at UK caring for my condition has been GREAT! Thanks to all!

    April, 2019

    April, 2019
    Dr. K is my radiation oncologist. All interactions with him and his staff have been exactly what I would have expected. I received excellent care. I'm grateful to have him as my physician.

Are you happy with the care you received from this provider?

Please let us know by filling out a patient satisfaction survey when you get one. You can also leave an online review by clicking the button below.

Leave a review